Tariffs on Denmark could drive up the already expensive cost of Novo Nordisk's popular Ozempic and Wegovy treatments
Bruce Gil is a journalist at various media outlets, focusing on medicine and healthcare, alternative medicine, and health and wellness. His work often intersects with themes of nutrition, markets, and public relations, reflecting his commitment to providing insightful coverage in these areas. Bruce has been featured in Knowledia, The Messenger, GBH, and numerous other prominent publications.